<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p>Diabetes mellitus is characterised by persistently elevated blood glucose levels. If left untreated or improperly treated for long periods this will result in widespread blood vessel damage and complications relating to the eyes, kidneys, heart, brain and nerves. There is an increased risk of lower limb amputations, poor fertility and pregnancy outcomes with improper glucose control.</p><p>Although children and adolescents often present with acute symptoms, many adults with diabetes are asymptomatic. It is therefore necessary to exclude diabetes in all persons, especially adults, attending health facilities for routine medical examinations, first out-patient review, ante-natal care, elective and emergency admissions or undergoing surgical procedures.</p><p>The non-pharmacological and pharmacological interventions in diabetes management are usually life-long.</p><p>Individuals found to have venous or capillary plasma glucose levels in the pre-diabetes or diabetes ranges, as shown in the table below, will need further assessment to confirm the diagnosis.</p><div class="table"><table><tbody><tr><td><strong>Fasting plasma glucose</strong></td><td><strong>2-hr post prandial plasma glucose</strong></td><td><strong>HbA1c</strong></td><td><strong>Status</strong></td></tr><tr><td>&lt; 5.6 mmol/L</td><td>&lt; 7.8 mmol/L</td><td>&lt;5.7%</td><td>Normal</td></tr><tr><td>&lt; 5.6 mmol/L</td><td>7.8 - 11.1 mmol/L</td><td>5.7 - 6.4 %</td><td>IGT (Pre-diabetes)</td></tr><tr><td>5.7-6.9 mmol/L</td><td>&lt; 7.8 mmol/L</td><td>5.7 - 6.4 %</td><td>IFG (Pre-diabetes)</td></tr><tr><td>&gt;7.0 mmol/L</td><td>&gt;11.1 mmol/L</td><td>&gt;6.5 %</td><td>Diabetes</td></tr><tr><td> </td><td> </td><td> </td><td> </td></tr></tbody></table></div><p><i>HbA1c - Glycated Haemoglobin IGT - Impaired Glucose Tolerance IFG - Impaired Fasting Glycaemia</i></p><p>Four forms of diabetes are encountered in practice:</p><ul><li>Type 1 diabetes</li><li>Type 2 diabetes</li><li>Gestational diabetes (See section on '<a href="diabetes_mellitus_in_pregnancy.html">Diabetes in Pregnancy</a>')</li><li>Secondary diabetes (related to medication use, endocrine or pancreatic disease etc.)</li></ul><p><strong>CAUSES</strong></p><ul><li>Autoimmune disorder (Type 1 diabetes)</li><li>Idiopathic (Type 1 diabetes)</li><li>Genetic factors causing a defect in the action or secretion of insulin (Type 2 diabetes)</li><li>Environmental factors e.g. excessive calorie intake and lack of physical activity (Type 2 diabetes)</li><li>Pregnancy (Gestational diabetes)</li><li>Secondary diabetes:</li><li>Medication e.g. corticosteroid use or abuse</li><li>Pancreatic disease or pancreatectomy</li><li>Endocrine disorders e.g. Cushing's syndrome, acromegaly etc.</li></ul><p><strong>SYMPTOMS</strong></p><ul><li>Usually none in many adults</li><li>Polyuria and nocturia</li><li>Polydipsia</li><li>Unexplained weight loss</li><li>Blurred vision</li><li>Recurrent boils</li><li>Recurrent pruritus vulvae</li><li>Erectile dysfunction</li><li>Symptoms related to chronic complications (e.g. 'pins and needles' sensation or numbness in the hands or feet, foot gangrene, poor vision etc.)</li><li>Delivery of large babies (&gt; 4 kg)</li></ul><p><strong>SIGNS</strong></p><ul><li>Usually none in most patients</li><li>Lack of sensation in the feet or hands</li><li>Foot gangrene</li><li>Pedal oedema</li><li>Impaired visual acuity</li><li>Cataract</li><li>Retinal changes on fundoscopy</li></ul><p><strong>INVESTIGATIONS</strong></p><p><strong>Newly diagnosed patient</strong></p><ul><li>Fasting or random blood glucose</li><li>Oral glucose tolerance test (if required to confirm diagnosis)</li><li>Blood urea, electrolytes and creatinine</li><li>Fasting blood lipid profile (adults)</li><li>Glycated haemoglobin (HbA1c)</li><li>FBC</li><li>ECG (adults)</li><li>Urinalysis</li><li>Urine ketones (with high initial glucose levels)</li></ul><p><strong>During routine follow ups</strong></p><ul><li>Blood glucose</li><li>Recorded results of regular self-monitoring of fasting and ran- dom tests at home by the patient using a glucose meter</li><li>Periodic fasting or random tests during clinic reviews</li><li>Glycated haemoglobin (HbA1c) (at least twice a year)</li><li>Blood lipid tests (annually, but more frequently if levels abnormal or on lipid lowering medication)</li><li>Blood urea, electrolytes and creatinine (annually, but more frequently if levels abnormal)</li><li>Urine microalbumin (annually)</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To relieve symptoms</li><li>To prevent acute hyperglycaemic complications (i.e. ketoacidosis and the hyperosmolar state)</li><li>To prevent treatment-related hypoglycaemia</li><li>To achieve and maintain appropriate glycaemic targets</li><li>Fasting blood glucose between 4-7 mmol/L (less intensive gly- caemic targets in elderly patients)</li><li>2-hour post-meal blood glucose between 5-9 mmol/L (less in- tensive glycaemic targetsin elderly patients)</li><li>Glycated haemoglobin 7 % or less (less intensive glycaemic tar- gets in elderly patients)</li><li>To ensure weight reduction in overweight and obese individuals</li><li>To prevent chronic complications of diabetes by maintaining</li><li>The glycaemic targets noted above</li><li>Blood pressure less than 130/80 mmHg</li><li>LDL-cholesterol less than 2.5 mmol/L</li></ul><p><strong>Non-pharmacological treatment</strong></p><div class="table"><table><tbody><tr><td><strong>Box 12-1: Therapeutic lifestyle modification</strong></td></tr><tr><td><p>Diet:</p><ul><li>Complex carbohydrates (e.g. kenkey, yam, plantain etc.) are preferred</li><li>Avoid refined sugars as in soft drinks, or adding sugar to beverages. Artificial sweeteners and 'diet' soft drinks, which do not contain glucose, may however be used</li><li>A day's diet must generally consist of;</li><li>Carbohydrates (60%), protein (15%) and fat (20%) mostly of plant-origin and low in animal fat</li><li>Salt (sodium chloride) &lt; 5 g/day</li><li>Fruits and vegetables 2" 400 g/day</li><li>Soluble fibre (e.g. as found in oats, beans, apples, nuts etc.)</li><li>A reduced total caloric content (portions) of food and an increase in the amount of fibre e.g. vegetables, fruits and cereals</li><li>Owing to the special needs of children for a diet that will ensure optimal growth, their diet must be determined by a dietician in consultation with a paediatrician</li></ul></td></tr><tr><td><p>Alcohol:</p><ul><li>Intake of alcohol is prohibited for individuals less than 18 years of age. While low consumption is permissible in adult patients, moderate to heavy drinking of alcohol increases the total caloric intake and may worsen over- weight and obesity. It may also increase the risk of hypoglycaemia</li></ul><p>Exercise:</p><ul><li>Regular, simple exercise e.g. 30 minutes brisk walking at least 3 days a week in ambulant patients</li><li>All advice on exercise must give consideration to the patient's age and the presence of complications and other medical conditions</li></ul></td></tr></tbody></table></div><p> </p><p><strong>Pharmacological treatment</strong></p><p><strong>A. Type 1 diabetes patients and Type 2 patients on insulin monotherapy</strong></p><div class="table"><table><tbody><tr><td><strong>Note 12-2</strong></td></tr><tr><td><p>Insulin dose requirements vary from patient to patient irrespective of age and body weight.</p><p>The total daily insulin requirement for most adults and pre-pubertal children  is about 0.6-0.8 units/kg, which should be given in divided doses. However, it  is prudent to begin with lower doses and build this up with time to prevent hypoglycaemia.</p><p>Insulin requirements increase during infections, puberty, periods of stress, accidental or surgical trauma, pregnancy etc.</p><p>The usual route for insulin injections for outpatient diabetes treatment is sub-cutaneous, administered 30 minutes before a meal for regular/soluble insulin, premix insulin, or NPH insulin and immediately before the meal for rapid acting analogue insulins (e.g. aspart, lispro) according to the following regimens:</p><ul><li>Twice daily pre-mixed insulin (soluble + intermediate acting insulin) before breakfast and supper (preferred)</li></ul><p>Or</p><ul><li>Twice daily injections of Soluble PLUS NPH 30 minutes before breakfast and Soluble PLUS NPH 30 minutes before supper. The Soluble and NPH insulins must be given in separate syringes.</li></ul></td></tr></tbody></table></div><p>Evidence Rating: [A]</p><ul><li>Insulin Premix, SC, (30% soluble insulin and 70% NPH insulin),</li></ul><p>½ of total daily insulin requirement 30 minutes before breakfast</p><p><strong>And</strong></p><p>½ of total daily insulin requirement 30 minutes before evening meal (supper)</p><p><strong>Or</strong></p><ul><li>Soluble insulin, SC,</li></ul><p>½ of total daily insulin requirement in 2 divided doses 30 minutes</p><p>before breakfast and supper</p><p><strong>And</strong></p><ul><li>Insulin NPH, SC,</li></ul><p>½ of total daily insulin requirement (½ of which would be given 30 minutes before breakfast and ½ 30 minutes before supper)</p><p><strong>B. Type 2 diabetes patients on oral medications; initial management</strong></p><p><strong>(Monotherapy)</strong></p><p>1st Line Treatment Evidence Rating: [A]</p><ul><li>Metformin, oral,</li></ul><p><strong>ADULTS</strong></p><p>500 mg-1 g daily</p><p><strong>Then</strong></p><p>Increase every 3 months to a maximum of 1 g 12 hourly if necessary</p><p><strong>CHILDREN</strong></p><p>Refer to specialist</p><p><strong>C. Type 2 diabetes patients on oral medications; patients not achieving glycaemic targets with Metformin monotherapy after approximately 3 months (Dual Therapy)</strong></p><ul><li>Metformin, oral,</li></ul><p><strong>ADULTS</strong></p><p>1 g 12 hourly</p><p><strong>CHILDREN</strong></p><p>Refer to specialist</p><p><strong>And</strong></p><ul><li>Glibenclamide, oral,</li></ul><p><strong>ADULTS</strong></p><p>2.5-10 mg daily (If required, not more than 5 mg of Glibenclamide could additionally be given in the evening maximum total dose 15 mg daily)</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><p><strong>Or</strong></p><ul><li>Gliclazide, oral,</li></ul><p><strong>ADULTS</strong></p><p>40-160 mg 12 hourly</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><p><strong>Or</strong></p><ul><li>Glimepiride, oral,</li></ul><p><strong>ADULTS</strong></p><p>2-6 mg daily (as a single dose in the morning)</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><p><strong>Or</strong></p><ul><li>Tolbutamide, oral,</li></ul><p><strong>ADULTS</strong></p><p>250-1000 mg 8-12 hourly</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><div class="table"><table><tbody><tr><td><strong>Note 12-2</strong></td></tr><tr><td>Tolbutamide is preferred in individuals with impaired renal function and in the elderly</td></tr></tbody></table></div><p> </p><p><strong>D. Type 2 diabetes patients on oral medications; patients not achieving glycaemic targets with combination of Metformin and Sulphonylurea e.g. Glibenclamide etc. after apoximately 3 months (Triple Therapy)</strong></p><p>1st Line Treatment Evidence Rating: [A]</p><ul><li>Metformin and Glibenclamide (or alternative), oral, as in section C above</li></ul><p><strong>And</strong></p><ul><li>Saxagliptin, oral,</li></ul><p><strong>ADULTS</strong></p><p>2.5-5 mg daily</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><p><strong>Or</strong></p><ul><li>Sitagliptin, oral,</li></ul><p><strong>ADULTS</strong></p><p>50-100 mg daily</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><p><strong>Or</strong></p><ul><li>Vildagliptin, oral,</li></ul><p><strong>ADULTS</strong></p><p>25-50 mg 12-24 hourly</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><p><strong>Or</strong></p><ul><li>Pioglitazone, oral,</li></ul><p><strong>ADULTS</strong></p><p>15-45 mg daily</p><p><strong>CHILDREN</strong></p><p>Not recommended</p><p><strong>E. Type 2 diabetes patients on oral medications; not achieving glycaemic targets with Triple Therapy</strong></p><ul><li>Triple Therapy</li></ul><p><strong>And</strong></p><ul><li>Insulin NPH, SC,</li></ul><p><strong>ADULTS</strong></p><p>2-20 units before bedtime</p><p><strong>CHILDREN</strong></p><p>Refer to specialist</p><div class="table"><table><tbody><tr><td><strong>Note 12-3</strong></td></tr><tr><td>Refer to a diabetologist or physician specialist for insulin and oral medication combination therapy in type 2 diabetes</td></tr></tbody></table></div><p> </p><p><strong>REFERRAL CRITERIA</strong></p><p>All individuals with diabetes must be referred to a dietician for dietary advice. All children with diabetes must be seen by a specialist (paediatrician or endocrinologist). All patients in whom glycaemic targets cannot be achieved as well as those with diabetes complications must be referred to the appropriate specialist.</p><p>All type 2 diabetics at diagnosis and type 1 diabetics 5 years after diagnosis should be referred to an eye specialist for screening for Diabetic Retinopathy.</p>
</body>
</html>
